Exenatide
Exenatide is an injected medicine that acts like GLP-1, a gut hormone released after eating. It slows the stomach, lowers appetite, and helps the body handle glucose. Exenatide was the first GLP-1 drug cleared for type 2 diabetes.
A woman with PCOS (polycystic ovary syndrome, now also called PMOS) may already be taking it for weight and blood sugar. In a trial of 60 women with PCOS and few ovulations, 86 percent ovulated on exenatide with metformin, against 29 percent on metformin alone.1
Most such trials used bleeding as a stand in for ovulation. The effect on true ovulation stays unclear.2
Cited in this entry
- Becker AS, Castilhos JP, Shugair SAS, Colombo T, Hentschke MR. GLP-1 Receptor Agonists and Fertility: What Is Known So Far?. JBRA assisted reproduction. 2026. https://pubmed.ncbi.nlm.nih.gov/42441883/
- Song E, Fang Y, Li X, Fu W, He H, Gao Z, Tian X, Gao B. Balancing metabolic optimization and reproductive safety in Polycystic Ovary Syndrome: a Bayesian-informed framework for GLP-1 receptor agonists. Frontiers in nutrition. 2026. https://pubmed.ncbi.nlm.nih.gov/42311951/
This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.
